Evaluation of indomethacin and dexamethasone effects on BCRP-mediated drug resistance in MCF-7 parental and resistant cell lines

References

• Andrews, P., Xu, Z., Allen, J., et al. (2008). A comparison of the effectiveness of selected non-steroidal anti-inflammatory drugs and their derivatives against cancer cells in vitro. Cancer Chemother Pharmacol 61:203–214.
   PubMed Web of Science ®Google Scholar
• Benyahia, B., Huguet, S., Decleves, X., et al. (2004). Multidrug resistance-associated protein MRP1 expression in human gliomas: chemosensitization to vincristine and etoposide by indomethacin in human glioma cell lines overexpressing MRP1. J Neurooncol 66:65–70.
   PubMed Web of Science ®Google Scholar
• Cha, Y. I., DuBois, R. N. (2007). NSAIDs and cancer prevention: targets downstream of COX-2. Annu Rev Med 58:239–252.
   PubMed Web of Science ®Google Scholar
• Cooray, H. C., Shahi, S., Cahn, A. P., et al. (2006). Modulation of P-glycoprotein and breast cancer resistance protein by some prescribed corticosteroids. Eur J Pharmacol 531:25–33.
   PubMed Web of Science ®Google Scholar
• Dmitrovsky, E. (2003). Combining cytotoxic chemotherapy with cyclooxygenase-2 inhibition. J Clin Oncol 21:2631–2632.
   PubMed Web of Science ®Google Scholar
• Doyle, L. A., Ross, D. D. (2003). Multidrug resistance mediated by the breast cancer resistance protein, BCRP (ABCG2). Oncogene 22:7340–7358.
   PubMed Web of Science ®Google Scholar
• Ee, P. L., Kamalakaran, S., Tonetti, D., et al. (2004). Identification of a novel estrogen response element in the breast cancer resistance protein (ABCG2) gene. Cancer Res 64:1247–1251.
   PubMed Web of Science ®Google Scholar
• El-Sheikh, A. A., van den Heuvel, J. J., Koenderink, J. B., et al. (2007). Interaction of nonsteroidal anti-inflammatory drugs with multidrug resistance protein (MRP) 2/ABCC2- and MRP4/ABCC4-mediated methotrexate transport. J Pharmacol Exp Ther 320:229–235.
   PubMed Web of Science ®Google Scholar
• Fardel, O., Lecureur, V., Guillouzo, A. (1993). Regulation by dexamethasone of P-glycoprotein expression in cultured rat hepatocytes. FEBS Lett 327:189–193.
   PubMed Web of Science ®Google Scholar
• Flescher, E., Rotem, R., Kwon, P., et al. (2000). Aspirin enhances multidrug resistance gene 1 expression in human Molt-4 T lymphoma cells. Anticancer Res 20:4441–4444.
   PubMed Web of Science ®Google Scholar
• Gedeon, C., Behravan, J., Koren, G., et al. (2006). Transport of glyburide by placental ABC transporters: implications in fetal drug exposure. Placenta 27:1096–1102.
   PubMed Web of Science ®Google Scholar
• Giercksky, K. E. (2001). COX-2 inhibition and prevention of cancer. Best Pract Res Clin Gastroenterol 15:821–833.
   PubMed Web of Science ®Google Scholar
• Gruol, D. J., Bourgeois, S. (1997). Chemosensitizing steroids: glucocorticoid receptor agonists capable of inhibiting P-glycoprotein function. Cancer Res 57:720–727.
   PubMed Web of Science ®Google Scholar
• Harris, R. E., Alshafie, G. A., Abou-Issa, H., et al. (2000). Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase-2 inhibitor. Cancer Res 60:2101–2103.
   PubMed Web of Science ®Google Scholar
• Honggang, W., Jashvant, D. U., Qingcheng, M. (2008). Hormonal regulation of BCRP expression in human placental BeWo cells. Pharm Res 25:444–452.
   PubMed Web of Science ®Google Scholar
• Howe, L. R., Subbaramaiah, K., Brown, A. M., et al. (2001). Cyclooxygenase-2: a target for the prevention and treatment of breast cancer. Endocr Relat Cancer 8:97–114.
   PubMed Web of Science ®Google Scholar
• Kang, H. K., Lee, E., Pyo, H., et al. (2005). Cyclooxygenase-independent downregulation of multidrug resistance-associated protein-1 expression by celecoxib in human lung cancer cells. Mol Cancer Ther 4:1358–1363.
   PubMed Web of Science ®Google Scholar
• Kismet, K., Akay, M. T., Abbasoglu, O., et al. (2004). Celecoxib: a potent cyclooxygenase-2 inhibitor in cancer prevention. Cancer Detect Prev 28:127–142.
   PubMedGoogle Scholar
• Kowalski, P., Stein, U., Scheffer, G. L., et al. (2002). Modulation of the atypical multidrug-resistant phenotype by a hammerhead ribozyme directed against the ABC transporter BCRP/MXR/ABCG2. Cancer Gene Ther 9:579–586.
   PubMed Web of Science ®Google Scholar
• Lin, J., Hsiao, P. W., Chiu, T. H., et al. (2005). Combination of cyclooxygenase-2 inhibitors and oxaliplatin increases the growth inhibition and death in human colon cancer cells. Biochem Pharmacol 70:658–667.
   PubMed Web of Science ®Google Scholar
• Matsunaga, S., Asano, T., Tsutsuda-Asano, A., et al. (2006). Indomethacin overcomes doxorubicin resistance with inhibiting multidrug resistance protein 1 (MRP1). Cancer Chemother Pharmacol 58:348–353.
   PubMed Web of Science ®Google Scholar
• Minderman, H., Suvannasaankha, A., O’Loughlin, K. L., et al. (2002). Flow cytometric analysis of breast cancer resistance protein expression and function. Cytometry 48:59–65.
   PubMedGoogle Scholar
• Mosaffa, F., Lage, H., Tavakol Afshari, J. et, al. (2009). Interleukin-1 beta and tumor necrosis factor-alpha increase ABCG2 expression in MCF-7 breast carcinoma cell line and its mitoxantrone-resistant derivative, MCF-7/MX. Inflamm Res 58:669–676.
   PubMed Web of Science ®Google Scholar
• Nakagawa, M., Schneider, E., Dixon, K. H. et al. (1992). Reduced intracellular drug accumulation in the absence of P-glycoprotein (mdr1) overexpression in mitoxantrone-resistant human MCF-7 breast cancer cells. Cancer Res 52:6175–6181.
   PubMed Web of Science ®Google Scholar
• Pavek, P., Merino, G., Wagenaar, E., et al. (2005). Human breast cancer resistance protein: interactions with steroid drugs, hormones, the dietary carcinogen, 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine, and transport of cimetidine. J Pharmacol Exp Ther 312:144–152.
   PubMed Web of Science ®Google Scholar
• Puhlmann, U., Ziemann, C., Ruedell, G., et al. (2005). Impact of the cyclooxygenase system on doxorubicin-induced functional multidrug resistance 1 overexpression and doxorubicin sensitivity in acute myeloid leukemic HL-60 cells. J Pharmacol Exp Ther 312:346–354.
   PubMed Web of Science ®Google Scholar
• Raspollini, M. R., Amunni, G., Villanucci, A., et al. (2005). Increased cyclooxygenase-2 (COX-2) and P-glycoprotein-170 (MDR1) expression is associated with chemotherapy resistance and poor prognosis. Analysis in ovarian carcinoma patients with low and high survival. Int J Gynecol Cancer 15:255–260.
   PubMed Web of Science ®Google Scholar
• Ratnasinghe, D., Daschner, P. J, Anver, M. R., et al. (2001). Cyclooxygenase-2, P-glycoprotein-170, and drug resistance: is chemoprevention against multidrug resistance possible? Anticancer Res 21:2141–2147.
   PubMed Web of Science ®Google Scholar
• Robey, R. W., Medina-Perez, W. Y., Nishiyama, K., et al. (2001). Overexpression of the ATP-binding cassette half-transporter, ABCG2 (Mxr/BCrp/ABCP1), in flavopiridol-resistant human breast cancer cells. Clin Cancer Res 7:145–152.
   PubMed Web of Science ®Google Scholar
• Roller, A., Bahr, O. R., Streffer, J., et al. (1999). Selective potentiation of drug cytotoxicity by NSAID in human glioma cells: the role of COX-1 and MRP. Biochem Biophys Res Commun 259:600–605.
   PubMed Web of Science ®Google Scholar
• Schinkel, A. H., Jonker, J. W. (2003). Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview. Adv Drug Deliv Rev 55:3–29.
   PubMed Web of Science ®Google Scholar
• Sorokin, A. (2004). Cyclooxygenase-2: potential role in regulation of drug efflux and multidrug resistance phenotype. Curr Pharm Des 10:647–657.
   PubMed Web of Science ®Google Scholar
• Spugnini, E. P., Cardillo, I., Verdina, A., et al. (2006). Piroxicam and cisplatin in a mouse model of peritoneal mesothelioma. Clin Cancer Res 12:6133–6143.
   PubMed Web of Science ®Google Scholar
• Sugimoto, Y., Tsukahara, S., Imai, Y., et al. (2003). Reversal of breast cancer resistance protein-mediated drug resistance by estrogen antagonists and agonists. Mol Cancer Ther 2:105–112.
   PubMed Web of Science ®Google Scholar
• Surowiak, P., Materna, V., Matkowski, R., et al. (2005). Relationship between the expression of cyclooxygenase-2 and MDR1/P-glycoprotein in invasive breast cancers and their prognostic significance. Breast Cancer Res 7:R862–R870.
   Google Scholar
• Tatebe, S., Sinicrope, F. A., Kuo, M. T. (2002). Induction of multidrug-resistance proteins MRP1 and MRP3 and gamma-glutamylcysteine synthetase gene expression by nonsteroidal anti-inflammatory drugs in human colon cancer cells. Biochem Biophys Res Commun 290:1427–1433.
   PubMed Web of Science ®Google Scholar
• Van der Kolk, D. M., Vellenga, E., Scheffer, G. L., et al. (2002). Expression and activity of breast cancer resistance protein (BCRP) in de novo and relapsed acute myeloid leukemia. Blood 99:3763–3770.
   PubMed Web of Science ®Google Scholar
• Van der Pol, M. A., Pater, J. M., Feller, N., et al. (2001). Functional characterization of minimal residual disease for P-glycoprotein and multidrug resistance protein activity in acute myeloid leukemia. Leukemia 15:1554–1563.
   PubMed Web of Science ®Google Scholar
• Van Wijngaarden J., van Beek, E., van Rossum G., et al. (2007). Celecoxib enhances doxorubicin-induced cytotoxicity in MDA-MB231 cells by NF-kappaB-mediated increase of intracellular doxorubicin accumulation. Eur J Cancer 43:433–442.
   PubMed Web of Science ®Google Scholar
• Verdina, A., Cardillo, I., Nebbioso, A., et al. (2008). Molecular analysis of the effects of piroxicam and cisplatin on mesothelioma cells growth and viability. J Transl Med 6:27.
   PubMedGoogle Scholar
• Yaming, S. U., Sung-Hack, L., Patrick, J. S. (2006). Inhibition of efflux transporter ABCG2/BCRP does not restore mitoxantrone sensitivity in irinotecan-selected human leukemia CPT-K5 cells: evidence for multifactorial multidrug resistance. Eur J Pharm Sci 29:102–110.
   PubMed Web of Science ®Google Scholar
• Zatelli, M. C., Luchin, A., Piccin, D.,et al. (2005). Cyclooxygenase-2 inhibitors reverse chemoresistance phenotype in medullary thyroid carcinoma by a permeability glycoprotein-mediated mechanism. J Clin Endocrinol Metab 90:5754–5760.
   PubMed Web of Science ®Google Scholar
• Zhao, J. Y., Ikeguchi, M., Eckersberg, T., et al. (1993). Modulation of multidrug resistance gene expression by dexamethasone in cultured hepatoma cells. Endocrinology 133:521–528.
   PubMed Web of Science ®Google Scholar
• Zrieki, A., Farinotti, R., Buyse, M. (2008). Cyclooxygenase inhibitors downregulate P-glycoprotein in human colorectal Caco-2 cell line. Pharm Res 25:1991–2001.
   PubMed Web of Science ®Google Scholar